Diphosphine-Diborane Complex for Stable Ligand Isolation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional synthesis methods for 2,2''-bis[1-(diphenylphosphino)ethyl]-1,1''-biferrocene (R P< -TRAP) face challenges such as the use of impractical reagents and solvents, instability, and complex purification processes, making industrial production difficult.
Innovation Solution
A novel method to produce the diphosphine-diborane complex R P< -TRAP·(BH 3 ) 2 by reacting a phosphine-borane complex with a magnesium source and an oxidizing agent, avoiding the use of synthetically challenging R P< -TRAP, resulting in a stable and easily isolable compound.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If conventional synthesis methods are used to produce 2,2''-bis[1-(diphenylphosphino)ethyl]-1,1''-biferrocene (R P< -TRAP), then the ligand can be obtained for catalytic reactions, but the synthesis process becomes complex, difficult to isolate and purify, and unsuitable for industrial production
Solution Approach 1:
The patent introduces a borane complex intermediate (R P< -TRAP·BH 3 or R P< -TRAP·(BH 3 ) 2 ) as a mediator in the synthesis process. Instead of directly synthesizing the target ligand R P< -TRAP through complex multi-step reactions, the invention uses borane adducts as stable intermediates that simplify the synthesis pathway, improve isolability, and enable easier purification while maintaining the ability to produce the desired catalytic ligand.
2Manufacturing precision
If conventional synthesis methods are used to produce R P< -TRAP, then the ligand can be obtained, but it becomes difficult to isolate and purify the compound
Solution Approach 1:
The patent changes the chemical parameters of the synthesis process by forming borane complexes (R P< -TRAP·BH 3 or R P< -TRAP·(BH 3 ) 2 ) as intermediates. This parameter change transforms the target molecule into a form with different physical and chemical properties, specifically improved crystallinity and stability, which directly enhances isolability and purification efficiency while maintaining the ability to ultimately produce the desired ligand.
3Reliability
If conventional synthesis methods are used to produce R P< -TRAP, then the ligand can be obtained, but the compound becomes unstable and difficult to store
Solution Approach 1:
The patent applies beforehand cushioning by pre-forming stable borane complex intermediates (R P< -TRAP·BH 3 or R P< -TRAP·(BH 3 ) 2 ) that protect the phosphine ligand from oxidation and degradation. These borane adducts act as protective forms that enhance air stability and extend storage duration, allowing the compound to be stored and handled more reliably before being converted to the active ligand form for catalytic applications.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The diphosphine-diborane complex exhibits excellent crystallinity, air stability, and facilitates easy purification and long-term storage, enhancing the efficiency of catalytic reactions like asymmetric hydrogenation of aromatics.
Implementation Method 1
A novel method to produce the diphosphine-diborane complex R P< -TRAP·(BH 3 ) 2 by reacting a phosphine-borane complex with a magnesium source and an oxidizing agent
Data Source
Figure 1~2
Figure 3~4
Figure 5~6
AI summary
The present invention pertains to: a stable equivalent of 2,2"-bis(1-phosphinoethyl)-1,1"-biferrocene or the like that is useful as a ligand in various catalytic reactions but is difficult to synthesize or isolate and purify; and a method for efficiently producing the stable equivalent. The present invention provides: a diphosphine-diborane complex represented by general formula (1·(BH3)2); and a method that is for producing the diphosphine-diborane complex, and that comprises sequentially reacting a magnesium source and an oxidizing agent with a phosphine-borane complex.